Senti Biosciences, Inc. (SNTI) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Senti Biosciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.81x | -0.31x | -0.41x | -1.06x | -7.78x | -21.94x |
| P/B Ratio | 41.84x | 0.63x | 0.44x | 0.49x | 7.13x | -7.42x |
| P/S Ratio | 10628.51x | 0.00x | 14.81x | 18.86x | 187.89x | 1105.83x |
| Profitability | ||||||
| Gross Margin | -16431.8% | 0.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -289668.2% | 0.0% | -4687.9% | -1889.3% | -1765.4% | -6267.5% |
| Net Margin | -279263.6% | 0.0% | -3592.4% | -1771.5% | -2414.6% | -5041.1% |
| EBITDA Margin | -273136.4% | 0.0% | -3100.9% | -1770.1% | -1634.0% | -5763.7% |
| Liquidity | ||||||
| Current Ratio | 1.67x | 4.49x | 5.62x | 5.68x | 4.04x | 6.52x |
| Quick Ratio | 1.67x | 4.49x | 5.62x | 5.68x | 4.04x | 6.52x |
| Leverage | ||||||
| Debt/Equity | 5.17x | 1.31x | 0.56x | 0.29x | 0.38x | -0.24x |
YoY = year-over-year change. Source: FMP..